首页> 外文期刊>World Journal of Gastroenterology >Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo
【24h】

Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo

机译:抑制剂RNA阻断体内丙型肝炎病毒内部核糖体进入位点介导的蛋白质翻译

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the inhibitory effect of hepatitis C virus internal ribosome entry site (HCV IRES) specific inhibitor RNA (IRNA) on gene expression mediated by HCV IRES in vivo. METHODS: By using G418 screening system, hepatoma cells constitutively expressing IRNA or mutant IRNA (mIRNA) were established and characterized, and HCV replicons containing the 5′ untranslated region (5′UTR) were constructed by using the same method. Cotransfection of pCMVNCRluc containing HCV 5′UTR-luc fusion genes and eukaryotic vector of IRNA into human hepatic carcinoma cells (HepG2) was performed and the eukaryotic expression plasmid of IRNA was transfected transiently into HCV replicons. pCMVNCRluc or pCDNA-luc was cotransfected with pSV40-β Gal into IRNA expressing hepatoma cells by using lipofectamine 2000 in vitro. Then the reporting gene expression level was examined at 48 h after transfection by using a luminometer and the expressing level of HCV C antigen was analysed with a confocal microscope. RESULTS: Transient expression of IRES specific IRNA could significantly inhibit the expression of reporter gene and viral antigen mediated by HCV IRES by 50% to 90% in vivo, but mIRNA lost its inhibitory activity completely. The luciferase gene expression mediated by HCV IRES was blocked in the HHCC constitutively expressing IRNA. At 48 h after transfection, the expression level of reportor gene descreased by 20%, but cap-dependent luciferase gene expression was not affected. IRNA could inhibit the HCV replicon expression 24 h after transfection and the highest inhibitory activity was 80% by 72 h, and the inhibitory activity was not increased until 7d after transfection. CONCLUSION: IRNA can inhibit HCV IRES mediated gene expression in vivo.
机译:目的:探讨丙型肝炎病毒内部核糖体进入位点(HCV IRES)特异性抑制剂RNA(IRNA)对HCV IRES介导的体内基因表达的抑制作用。方法:利用G418筛选系统,构建并鉴定组成型表达IRNA或突变型IRNA(mIRNA)的肝癌细胞,并用相同方法构建含有5'非翻译区(5'UTR)的HCV复制子。将含有HCV 5'UTR-luc融合基因的pCMVNCRluc和IRNA的真核载体共转​​染到人肝癌细胞(HepG2)中,并将IRNA的真核表达质粒瞬时转染到HCV复制子中。使用lipofectamine 2000,将pCMVNCRluc或pCDNA-luc与pSV40-βGal共转染到表达IRNA的肝癌细胞中。然后,在转染后48小时,使用光度计检查报告基因的表达水平,并用共聚焦显微镜分析HCV C抗原的表达水平。结果:IRES特异性IRNA的瞬时表达可在体内将HCV IRES介导的报告基因和病毒抗原的表达抑制50%至90%,而mIRNA则完全丧失其抑制活性。 HCV IRES介导的萤光素酶基因表达在组成性表达IRNA的HHCC中被阻断。转染后48 h,报告基因的表达水平下降了20%,但帽依赖性荧光素酶基因的表达未受到影响。转染后24 h,IRNA可以抑制HCV复制子的表达,到72 h抑制活性最高为80%,直到转染后7d抑制活性才增加。结论:IRNA在体内可抑制HCV IRES介导的基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号